Unknown PHASE2 INTERVENTIONAL 2-arm NCT04572477

The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome

Sponsor: Chang Gung Memorial Hospital

Conditions Post-stroke Dementia, Vascular Mild Cognitive Impairment

Updated 9 times since 2020 Last updated: May 2, 2023 Started: Jun 1, 2017 Primary completion: Nov 30, 2023 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Post-stroke Dementia, Vascular Mild Cognitive Impairment and is currently ongoing. Chang Gung Memorial Hospital leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
May 2025 — Sep 2025 [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — May 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jun 2023 — Jul 2024 [monthly]

Recruiting PHASE2

▶ Show 4 earlier versions

Nov 2021 — Jun 2023 [monthly]

Recruiting PHASE2
Jan 2021 — Nov 2021 [monthly]

Recruiting PHASE2
Nov 2020 — Jan 2021 [monthly]

Recruiting PHASE2
Oct 2020 — Nov 2020 [monthly]

Recruiting PHASE2

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chang Gung Memorial Hospital

Data source: Chang Gung Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taoyuan District, Taiwan